Latest Cervarix Stories
One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.
ATLANTA - One in four teen girls have rolled up their sleeves for the relatively new vaccine against cervical cancer, federal health officials said Thursday.
ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine technology is exclusively licensed from Cedars-Sinai Medical Center.
By JAN DISLEY A CATHOLIC school is set to become the first in the country to ban the new cervical cancer jabs. Governors who have already criticised the jabs for "encouraging sexual promiscuity" now say they won't allow pupils to be vaccinated on school grounds.
The new vaccination for girls against cervical cancer has been welcomed by Swansea East AM Val Lloyd.
SCHOOLGIRLS in Bridgend will start to receive a cervical cancer vaccine next month. The programme against the human papilloma virus will be rolled out to 12 and 13-year-old girls at secondary schools in the borough.
By Mark Branagan Hull Teaching Primary Care Trust is taking part in a national immunisation programme by offering the Human Papilloma Virus (HPV) vaccine to girls aged 12 and 13 through the local school nursing service.
By Catherine Vonledebur, HEALTH REPORTER Health chiefs in Coventry are launching a vaccination programme to protect 2,000 girls against the main cervical cancer virus.
The U.S. Food and Drug Administration has expanded the use of the cervical vaccine Gardasil for the prevention of vaginal and vulvar cancers.
A study by researchers in Italy has found that a new cervical cancer test is more accurate than conventional pap smears at detecting dangerous pre-cancerous lesions.
- A political dynamiter.